Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase NA 16Phase 3 8Phase 2/3 3Phase 4 1Phase 1 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 54INDUSTRY 15FED 3OTHER_GOV 2NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Uterine Cervical Dysplasia 1Ototoxicity 1Neoplasm Metastasis 1Lymphatic Abnormalities 1Lymphangioma, Cystic 1Lymphangioma 1Health Education 1Colorectal Neoplasms 1Bowen's Disease 1

Interventions

relugolix 1nilutamide 1histrelin 1enzalutamide 1bicalutamide 1apalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abiraterone 1Triptorelin Pamoate 1Prednisone 1Methylprednisolone 1Leuprolide 1Goserelin 1Flutamide 1Androgen Antagonists 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × FED × Prostatic Neoplasms × Clear all
NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting
464 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT03852654 2019-02-25

18F-DCFPyL PET-CT Scan and Prostate Cancer

VA Greater Los Angeles Healthcare System

Phase 2/3 Unknown
170 enrolled
Genitourinary

Prostatic Neoplasms

NCT00164437 2005-09-14

CD-ROM Intervention for Prostate Cancer Screening

Centers for Disease Control and Prevention

Phase 2/3 Completed
554 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡